Literature DB >> 21252946

Modified visual field test for ptosis surgery (Leicester Peripheral Field Test).

S F Ho1, A Morawski, R Sampath, J Burns.   

Abstract

INTRODUCTION: There is lack of consensus among Primary Health Care Trusts (PCTs) and health insurers on how to reimburse ptosis surgery and upper lid blepharoplasty, as these procedures can be regarded as cosmetic. Standardised photographs are expensive and difficult to achieve, whilst the routine 24-2 visual field lacks the range to detect visually significant superior field defects.AimTo introduce a modified visual field designed to assess the functional disability associated with ptosis and dermatochalasis and to demonstrate the effectiveness of surgery in improving the visual field.
METHODS: Patients who had surgery for ptosis or dermatochalasis between January 2006 and December 2009 were prospectively invited to perform a modified visual field test pre- and post-operatively.
RESULTS: In total, 97 patients amounting to 194 eyes were included in the study. Ninety five eyes had aponeurotic repair with or without blepharoplasty and 77 eyes had blepharoplasty alone. This modified test has a sensitivity of 98.8% of detecting ptosis. For patients who underwent ptosis surgery with or without blepharoplasty, 84.2% recorded an improvement in points seen with the test and 81% recorded an improvement in visual field height. For those who had blepharoplasty alone, 90.9% recorded an improvement in points seen in the modified visual field test and 80.6% had improvement in visual field height.
CONCLUSION: Our modified visual field assessment is a quick and easy way to assess patient disability associated with ptosis and dermatochalasis. Surgery improves the demonstrated defect, confirming that ptosis and dermatochalasis can be considered a functional rather than cosmetic issue.

Entities:  

Mesh:

Year:  2011        PMID: 21252946      PMCID: PMC3178305          DOI: 10.1038/eye.2010.210

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  12 in total

1.  Does anyone know how to differentiate a 'functional' defect from a cosmetic one?

Authors:  R L Anderson; J B Holds
Journal:  Arch Ophthalmol       Date:  1990-12

2.  Functional vs cosmetic ophthalmologic defects.

Authors:  R G Small
Journal:  Arch Ophthalmol       Date:  1991-09

Review 3.  Functional eyelid surgery.

Authors:  D R Meyer
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1997-06       Impact factor: 1.746

4.  The measurement and definition of ptosis.

Authors:  R G Small; N R Sabates; D Burrows
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1989       Impact factor: 1.746

5.  Quantitating the superior visual field loss associated with ptosis.

Authors:  D R Meyer; J V Linberg; S R Powell; J V Odom
Journal:  Arch Ophthalmol       Date:  1989-06

6.  Downgaze ptosis.

Authors:  T H Wojno
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1993-06       Impact factor: 1.746

7.  Evaluating the visual field effects of blepharoptosis using automated static perimetry.

Authors:  D R Meyer; J H Stern; J M Jarvis; L L Lininger
Journal:  Ophthalmology       Date:  1993-05       Impact factor: 12.079

8.  Worsening of blepharoptosis in downgaze.

Authors:  R M Dryden; D A Kahanic
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1992       Impact factor: 1.746

9.  Investigation of automated perimetry in the evaluation of patients for upper lid blepharoplasty.

Authors:  H D Hacker; D A Hollsten
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1992       Impact factor: 1.746

10.  The effect of blepharoptosis on the field of vision.

Authors:  K V Cahill; J A Burns; P A Weber
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1987       Impact factor: 1.746

View more
  9 in total

1.  Brow ptosis: are we measuring the right thing? The impact of surgery and the correlation of objective and subjective measures with postoperative improvement in quality-of-life.

Authors:  F Mellington; R Khooshabeh
Journal:  Eye (Lond)       Date:  2012-05-18       Impact factor: 3.775

2.  Effects of upper lid blepharoplasty on visual quality in patients with lash ptosis and dermatochalasis.

Authors:  Seoung Hyun An; Sang Wook Jin; Yoon Hyung Kwon; Won Yeol Ryu; Woo Jin Jeong; Hee Bae Ahn
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

3.  Tangent screen perimetry in the evaluation of visual field defects associated with ptosis and dermatochalasis.

Authors:  Molly L Fuller; César A Briceño; Christine C Nelson; Elizabeth A Bradley
Journal:  PLoS One       Date:  2017-03-29       Impact factor: 3.240

Review 4.  A review of acquired blepharoptosis: prevalence, diagnosis, and current treatment options.

Authors:  Jason Bacharach; Wendy W Lee; Andrew R Harrison; Thomas F Freddo
Journal:  Eye (Lond)       Date:  2021-04-29       Impact factor: 3.775

5.  Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials.

Authors:  David L Wirta; Michael S Korenfeld; Shane Foster; Robert Smyth-Medina; Jason Bacharach; Shane R Kannarr; Mark J Jaros; Charles B Slonim
Journal:  Clin Ophthalmol       Date:  2021-10-08

6.  Evaluating the Effects of Upper Eyelid Blepharoplasty on Tear Film Quality and Intraocular Pressure.

Authors:  Ibrahim Cagri Turker; Ceylan Uslu Dogan
Journal:  Beyoglu Eye J       Date:  2020-12-28

7.  Is formal visual field testing essential prior to upper eyelid surgery in a post-COVID-19 era?

Authors:  Magnus Theodorsson; Cristina Soare; Oana Vonica; Hooman Sherafat
Journal:  Eye (Lond)       Date:  2020-07-21       Impact factor: 3.775

8.  Application of Second-Generation Swept-Source Anterior Segment-OCT in the Measurement of Marginal Reflex Distance-1 (MRD-1).

Authors:  Kosuke Ogasawara
Journal:  Clin Ophthalmol       Date:  2020-03-03

9.  Patient reported psychosocial functioning following successful ptosis surgery.

Authors:  H S Richards; E Jenkinson; P White; R A Harrad
Journal:  Eye (Lond)       Date:  2021-07-29       Impact factor: 4.456

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.